![Mark A. Gohr](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark A. Gohr
Direttore Finanziario/CFO presso ANTH1, Inc.
Posizioni attive di Mark A. Gohr
Società | Posizione | Inizio | Fine |
---|---|---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Comptroller/Controller/Auditor | 17/06/2010 | - |
Direttore Finanziario/CFO | 17/06/2010 | - | |
Direttore/Membro del Consiglio | 17/07/2008 | 17/06/2010 |
Storia della carriera di Mark A. Gohr
Formazione di Mark A. Gohr
The University of Colorado | Graduate Degree |
Hastings College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Health Technology |
- Borsa valori
- Insiders
- Mark A. Gohr
- Esperienza